Pharma Industry News

Otsuka, Amalgam partner on Alzheimer’s care tech; Hello Heart joins Amwell’s telehealth network

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Otsuka and Amalgam partner on Alzheimer’s care tech

Precision health company Otsuka — which, you may remember, decided to price its depression digital therapeutic lower to make it more accessible even if it’ll lose money on it — is now partnering with Amalgam on an app for the caregivers of Alzheimer’s patients. The app, called Elevmi, is based on a large language model trained on information from the National Institute on Aging and an online mental health site, PsychU.
Read the rest…

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Otsuka and Amalgam partner on Alzheimer’s care tech

Precision health company Otsuka — which, you may remember, decided to price its depression digital therapeutic lower to make it more accessible even if it’ll lose money on it — is now partnering with Amalgam on an app for the caregivers of Alzheimer’s patients. The app, called Elevmi, is based on a large language model trained on information from the National Institute on Aging and an online mental health site, PsychU.

Read the rest…

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]